PMGC Holdings ELAB
NASDAQ ELAB
$6.66 +0.56 (+9.18%)
At close: Aug 21, 2026 · 4:00 PM EDT

PMGC Holdings (ELAB) Profit After Tax (2022 - 2026)

PMGC Holdings (ELAB) posted Profit After Tax of -$5.0 million for Q1 2026, down 67.19% sequentially from -$3.0 million in Q4 2025, and down 4577.37% YoY from $111377.0 in Q1 2025.

PMGC Holdings (ELAB) Profit After Tax (2022 - 2026) Analysis & Trends

PMGC Holdings has reported Profit After Tax for 5 years, with the latest figure at -$5.0 million in Q1 2026.

  • Quarterly Profit After Tax fell 4577.37% year-over-year to -$5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10.6 million (down 321.0% YoY) and the FY2025 annual result came in at -$7.7 million, down 92.89% from the prior year.
  • Profit After Tax declined to -$5.0 million in Q1 2026 per ELAB's latest filing, from -$3.0 million in the prior quarter.
  • Over five years, Profit After Tax peaked at $1.1 billion in Q4 2022 and troughed at -$499.3 million in Q3 2022.
  • A 5-year average of $41.8 million and a median of -$1.3 million in 2023 frame the typical range for Profit After Tax.
  • The sharpest annual moves came in 2024 and 2026: Profit After Tax soared 125.4% in 2024, then sank 4577.37% in 2026.
  • Over 5 years, Profit After Tax stood at $1.1 billion in 2022, then sank by 100.1% to -$1.2 million in 2023, then jumped by 125.4% to $294284.0 in 2024, then tumbled by 1113.54% to -$3.0 million in 2025, then tumbled by 67.19% to -$5.0 million in 2026.
  • According to Business Quant data, Profit After Tax over the past three periods registered -$5.0 million, -$3.0 million, and -$2.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -782.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 237.01 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 164.49 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -355.03 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -16.62 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 81.49 Mn
10 PMGC Holdings 31.22 Mn 12.43 Mn 385,691.00 -2.96 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.99 Mn
Dec 31, 2025 -2.98 Mn
Sep 30, 2025 -2.59 Mn
Jun 30, 2025 -2.00
Mar 31, 2025 111,377.00
Dec 31, 2024 294,284.00
Sep 30, 2024 -1.50 Mn
Jun 30, 2024 -1.41 Mn
Mar 31, 2024 -1.40 Mn
Dec 31, 2023 -1.16 Mn
Sep 30, 2023 -782,660.00
Jun 30, 2023 -1.28 Mn
Mar 31, 2023 -1.08 Mn
Dec 31, 2022 1.15 Bn
Sep 30, 2022 -499.31 Mn